Receive Email Updates
Certified Licensing Professionals, Inc., 2021
This blog, Patents4Life, does not contain legal advice and is for informational purposes only. Its publication does not create an attorney-client relationship nor is it a solicitation for business. This is the personal blog of Warren Woessner and does not reflect the views of Schwegman Lundberg & Woessner, or any of its attorneys or staff. To the best of his ability, the Author provides current and accurate information at the time of each post, however, readers should check for current information and accuracy.
- About Me
Warren D. Woessner
Category Archives: Non-U.S. Practice
From SLW International: Info on the Unitary Patent and the Unified Patent Court
Guest contribution from SLW International: A short paper with information on the Unitary Patent and the Unified Patent Court can be found here.
New Edition of C.I.P.A. Guide to Patent Acts Published
This “Guide” is a 1528 page book published by the Chartered Institute of Patent Attorneys via Thomson Reuters, and edited by Paul Cole and Richard Davis. Of course, it mostly focused on UK patent law, but draws upon a variety … Continue reading
Posted in Non-U.S. Practice Tagged Australia, canada, EPO Leave a comment
Do You Really Want to File for Pharma Patent Protection in Canada, India or Ecuador?
IPO Letter Reports Weaknesses in IP Protection Around the World In a 27 page letter dated February 8, 2018 and sent to Sue Chang at the Office of the U.S. Trade Representative, the Executive Director of IPO, Mark Lauroesch, extensively … Continue reading
Posted in Govt Policy/PTO Policy, Int'l Practice and Policy, Non-U.S. Practice Tagged Global IP, International IP, IPO 1 Comment
Patenting “Natural Products” Down-Under Post-Myriad
Although the Australian High Court held that claims to naturally occurring DNA (e.g., BRCA1 nucleic acid) were not patent eligible because they were not a “manner of manufacture,” since the encoded information therein was not “made” by human action, in … Continue reading
Posted in Non-U.S. Practice Tagged Australia, biotechnology, biotechnology law, biotechnology news, intellectual property, ip, Myriad, Patent Law, Warren Woessner 1 Comment